Richard Orji
Cardiovascular Disease · Chicago, ILNPI 1447832985
Payments from drug & device makers
Across 79 payments — averaging $40.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$388
- Pfizer$386
- Novartis$383
- Abbott$350
- Edwards Lifesciences$347
- Medtronic$200
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,94691%
- Education$2889%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 9 | $388 |
| Pfizer | 16 | $386 |
| Novartis | 19 | $383 |
| Abbott | 5 | $350 |
| Edwards Lifesciences | 2 | $347 |
| Medtronic | 4 | $200 |
| Inari Medical, Inc. | 1 | $162 |
| W. L. Gore & Associates, Inc. | 1 | $160 |
| Asahi Intecc USA, Inc. | 1 | $155 |
| Merck | 3 | $136 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $124 |
| Novo Nordisk | 1 | $117 |
| Boston Scientific | 3 | $85 |
| AstraZeneca | 3 | $56 |
| Boehringer Ingelheim | 1 | $34 |
| Cardiva Medical, Inc. | 1 | $34 |
| Lantheus Medical Imaging, Inc. | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Bayer | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Bridgebio Pharma, Inc. | 1 | $19 |
| Chiesi USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,234 in reported general payments places this provider in the 60th percentile of 932 cardiovascular disease providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spironolactone | 11 | $69 |
| Furosemide | 12 | $27 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Chicago
- Benjamin LumicaoChicago$3.7M
- Paul CremerChicago$2.9M
- Nitasha SarswatChicago$2M
- Sanjiv ShahChicago$1.2M
- Sandeep NathanChicago$1.1M
- Boaz AvitallChicago$663K
- Ravi PatelChicago$488K
- Lubna ChoudhuryChicago$476K
- Akhil NarangChicago$427K
- Amit AminChicago$407K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.